Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland

被引:7
|
作者
Guest, Julian F. [1 ,2 ]
Weidlich, Diana [1 ]
Kaczmarski, Maciej [3 ]
Jarocka-Cyrta, Elzbieta [4 ]
Kobelska-Dubiel, Natalia [5 ]
Krauze, Agnieszka [6 ]
Sakowska-Maliszewska, Iwona [7 ]
Zawadzka-Krajewska, Anna [8 ]
机构
[1] Catalyst Hlth Econ Consultants, 34b High St, Northwood HA6 1BN, Middx, England
[2] Kings Coll London, Fac Life Sci & Med, London, England
[3] Med Univ Bialystok, Dept Pediat Gastroenterol & Allergol, Bialystok, Poland
[4] Uniwersytet Warminsko Mazurski, Wydzial Nauk Med, Katedra Pediat Klin, Olsztyn, Poland
[5] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland
[6] Klin Pneumonol & Alergol Wieku Dzieciecego, Warsaw, Poland
[7] Poradnia Gastroenterol Ctr Pediat, Sosnowiec, Poland
[8] Med Univ Warsaw, Dept Pediat Pneumonol & Allergol, Warsaw, Poland
关键词
amino acid formula; cost-effectiveness; cow's milk allergy; extensively hydrolyzed formula; Lactobacillus Rhamnosus GG; Poland;
D O I
10.2147/CEOR.S105748
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To estimate the cost-effectiveness of using an extensively hydrolyzed casein formula (eHCF) containing the probiotic Lactobacillus rhamnosus GG (eHCF + LGG; Nutramigen LGG) as an initial treatment for cow's milk allergy compared with eHCF alone and amino acid formulas (AAF) in Poland from the perspective of the Polish National Health Fund (Narodowy Fundusz Zdrowia [NFZ]) and parents. Methods: Decision modeling was used to estimate the probability of cow's milk allergic infants developing tolerance to cow's milk by 18 months. The model also estimated the cost to the NFZ and parents (Polish Zloty [PLN] at 2013-2014 prices) for managing infants over 18 months after starting one of the formulas as well as the relative cost-effectiveness of each of the formulas. Results: The probability of developing tolerance to cow's milk by 18 months was higher among infants who were fed eHCF + LGG (0.82) compared with those fed eHCF alone (0.53) or an AAF (0.22). An infant who is initially managed with eHCF + LGG is expected to consume fewer health care resources than infants managed with the other formulas. Hence, the estimated total health care cost incurred by the NFZ for initially feeding infants with eHCF + LGG (PLN 5,693) was less than that of feeding infants with eHCF alone (PLN 7,749) or an AAF (PLN 24,333). However, the total cost incurred by parents for initially feeding infants with an AAF (PLN 815) was marginally less than that of feeding with eHCF + LGG (PLN 993), which was less than that of feeding with eHCF alone (PLN 1,226). Conclusion: Using eHCF + LGG instead of eHCF alone or an AAF for first-line management of newly diagnosed infants with cow's milk allergy affords a cost-effective use of NFZ-funded resources, since it improves outcome for less cost. Whether eHCF + LGG would be viewed as being cost-effective by parents is dependent on their willingness to pay an additional cost for additional tolerance acquisition to cow's milk.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [41] Managing Cow's Milk Protein Allergy with an Extensively Hydrolyzed Formula: Results from a Prospective, Non-Interventional Study in France (EVA Study)
    Lemale, Julie
    Decline, Jean-Luc
    Dive-Pouletty, Catherine
    Touboul, Chantal
    Pichon, Nadege
    Dupont, Christophe
    [J]. NUTRIENTS, 2022, 14 (06)
  • [42] Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow’s Milk Protein Allergy: a Randomised Double-Blind Placebo-Controlled Trial
    Ahmet Basturk
    İshak Isik
    Atike Atalay
    Aygen Yılmaz
    [J]. Probiotics and Antimicrobial Proteins, 2020, 12 : 138 - 143
  • [43] Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow's Milk Protein Allergy: a Randomised Double-Blind Placebo-Controlled Trial
    Basturk, Ahmet
    Isik, Ishak
    Atalay, Atike
    Yilmaz, Aygen
    [J]. PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2020, 12 (01) : 138 - 143
  • [44] Managing Cow's Milk Protein Allergy in Indonesia: A Cost-effectiveness Analysis of Hypoallergenic Milk Formulas From the Private Payers' Perspective
    Paquete, Ana Teresa
    Martins, Rui
    Connolly, Mark P.
    Hegar, Badriul
    Munasir, Zakiudin
    Stephanus, Stephanus
    [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 77 - 85
  • [45] The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow's Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study
    Cukrowska, Bozena
    Ceregra, Aldona
    Maciorkowska, Elzbieta
    Surowska, Barbara
    Zegadlo-Mylik, Maria Agnieszka
    Konopka, Ewa
    Trojanowska, Ilona
    Zakrzewska, Magdalena
    Bierla, Joanna Beata
    Zakrzewski, Mateusz
    Kanarek, Ewelina
    Motyl, Ilona
    [J]. NUTRIENTS, 2021, 13 (04)
  • [46] Synbiotic containing extensively hydrolyzed formula improves gastrointestinal and atopic symptom severity, growth, caregiver quality of life, and hospital-related healthcare use in infants with cow's milk allergy
    Hubbard, Gary P.
    Atwal, Kiranjit
    Graham, Lynne
    Narayanan, Sankara
    Cooke, Lisa
    Casewell, Catherine
    Denton, Sally-Ann
    Gavin, Joan
    Browne, Robert M.
    Kinnear, Fiona J.
    McHardy, Ailsa J.
    Evans, Debbie
    Vallis, Rachel
    Venkataraman, Devasmitha
    Cawood, Abbie L.
    Donohoe, Sarah
    Steele, Victoria
    Armstrong, Sonia
    Stratton, Rebecca J.
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (06)
  • [47] Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial
    Vandenplas, Yvan
    Zolnowska, Marta
    Berni Canani, Roberto
    Ludman, Sian
    Tengelyi, Zsuzsanna
    Moreno-alvarez, Ana
    Goh, Anne E. N.
    Gosoniu, Maria Laura
    Kirwan, Bridget-Anne
    Tadi, Monika
    Heine, Ralf G.
    [J]. NUTRIENTS, 2022, 14 (03)
  • [48] The evaluation of tolerance rate and the immune tolerance acquisition in children affected by IgE-mediated cow′s milk allergy switching from amino acid-based formula to extensively hydrolyzed casein formula: the SDACMA project
    Nocerino, R.
    Cosenza, L.
    Lettieri, M.
    Carucci, L.
    Coppola, S.
    Voto, L.
    Paparo, L.
    Canani, Berni R.
    [J]. ALLERGY, 2023, 78 : 16 - 16
  • [49] MODELING THE COST-EFFECTIVENESS OF 100% WHEY-BASED PARTIALLY HYDROLYZED VERSUS. COW'S MILK INFANT FORMULA IN THE PREVENTION OF ATOPIC DERMATITIS IN SINGAPORE
    Bhanegaonkar, A.
    Lee, B. W.
    Chil, Shek Pei L.
    Van Bever, H.
    Horodniceanu, E. G.
    Ji, X.
    Detzel, P.
    Botteman, M. F.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A779 - A779
  • [50] Real-life data on the effectiveness of extensively hydrolyzed protein-based formula and amino acid-based formula in regaining weight and height in infants on a cow's milk protein elimination diet
    de Faria, Dayane Pedra Batista
    de Sillos, Marcela Duarte
    Speridiao, Patricia da Graca Leite
    de Morais, Mauro Batista
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (02) : 177 - 183